Sociedad Americana de Hirudoterapia

Taxonomic update and DNA barcoding of Tunisian nasal leeches (Annelida: Hirudiniformes; Praobdellidae): confirming Limnatis nilotica and revealing a second Limnatis species in North Africa

Taxonomic study published in Invertebrate Systematics (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genómica y proteómicaSeguridad y control de infeccionesBen Ahmed R et al. · Invertebrate Systematics, 2025

Abstract

Leeches of the genus Limnatis are known ectoparasites of vertebrates, including humans and domestic animals, with some species causing significant health complications. In this study, we describe Limnatis anouarensis sp. nov., a new nasal leech species from Tunisia and compare it with Limnatis nilotica sensu stricto from Tunisia and Morocco. Morphological analyses were conducted using light and scanning electron microscopy, focusing on external and internal structures. Additionally, mitochondrial (cytochrome c oxidase subunit I, COI; 12S rRNA, 12S) and nuclear (28S rRNA, 28S) gene fragments were sequenced for molecular characterisation. The new species is distinguished by its larger size, distinct reproductive system morphology and unique dorsal colouration, characterised by a median orange band and marginal orange stripes, in contrast to the black-striped pattern of L. nilotica (Moore, 1938). Molecular analyses confirmed that mitochondrial markers provide reliable species identification, whereas the analysed fragment of 28S gene was fully conserved and unsuitable for differentiation. These findings confirm the presence of at least two distinct Limnatis species in North Africa, emphasising the need for further taxonomic and ecological studies to clarify their distribution, host specificity and potential medical significance. ZooBank: urn:lsid:zoobank.org:pub:7CA59D0E-1D42-4A02-B886-D198DD88E698.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsDNA Barcoding, TaxonomicLeechesTunisiaSpecies SpecificityPhylogenyAfrica, NorthernElectron Transport Complex IVRNA, Ribosomal, 28S

Resumen

Describes Limnatis anouarensis sp. nov., a new North African nasal leech species (vertebrate ectoparasite causing public health complications) distinguished by morphology and mitochondrial COI/12S markers from Limnatis nilotica.

Por qué esto importa para la hirudoterapia

This taxonomic study describes Limnatis anouarensis sp. nov., a newly identified nasal leech species from Tunisia, and compares it morphologically and molecularly with Limnatis nilotica sensu stricto using light and scanning electron microscopy plus mitochondrial (COI, 12S) and nuclear (28S) DNA sequencing. The new species is distinguished by larger size, distinct reproductive system morphology, and unique dorsal coloration featuring a median orange band and marginal orange stripes versus the black-striped pattern of L. nilotica. While this study involves leeches, its focus is purely systematic; these are parasitic nasal leeches of vertebrates, not the medicinal leeches used in hirudotherapy. The findings have no direct relevance to therapeutic leech application or the leech secretome, and any noted medical significance relates to parasitic infestation rather than therapeutic use.

Citación

Taxonomic update and DNA barcoding of Tunisian nasal leeches (Annelida: Hirudiniformes; Praobdellidae): confirming Limnatis nilotica and revealing a second Limnatis species in North Africa.

Ben Ahmed R et al. · Invertebrate Systematics, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.